• Prestained Protein Marker: Triple-Color Workflow

  2026-08-18

  The Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) provides visible molecular-weight reference bands for monitoring SDS-PAGE separation and checking protein transfer during Western blotting. It is intended for denaturing electrophoresis, membrane-transfer assessment, Phosbind workflows, and fluorescent imaging, but not for direct protein quantification or native-protein analysis.

• AL-8810: A Precision Prostaglandin F2α Antagonist

  2026-08-17

  AL-8810 provides a pharmacological route to dissect FP receptor biology across endometrial, vascular, and smooth muscle models. This thought-leadership guide connects mechanistic findings from a mouse menstrual-like model with experimental strategy, assay design, translational boundaries, and practical reagent handling.

• Temafloxacin Workflows for Antibacterial Research

  2026-08-17

  Temafloxacin supports concentration-controlled studies spanning standard MIC testing, respiratory infection models, atypical pathogens, and intracellular mycobacterial assays. This guide combines practical assay design with a data-driven optimization strategy inspired by engineered antibiotic production research.

• Fast-Dissociating Antibodies in Single-Molecule Screening

  2026-08-16

  Miyoshi and colleagues developed a semi-automated single-molecule TIRF assay to identify specific antibodies with rapid antigen dissociation directly from hybridoma cultures. The study shows that transient binding can support multiplexed super-resolution imaging and reveal rapid espin turnover in the stable actin cores of inner-ear stereocilia.

• IWR-1-endo: From Pathway Control to Translation

  2026-08-15

  Translational research increasingly depends on connecting cell-resolved discovery with causal pathway perturbation. This thought-leadership article examines how IWR-1-endo, a Wnt signaling inhibitor, can sharpen experimental interpretation in colorectal cancer research, stem-cell biology, and carefully bounded cross-domain studies inspired by single-nucleus profiling in atrial fibrillation.

• CCG-1423: A RhoA Inhibitor for Pathway Mapping

  2026-08-14

  CCG-1423 is a mechanistically selective RhoA inhibitor for separating MRTF-A nuclear transport from acute actomyosin signaling. This guide shows how to apply it in cancer research and cautiously extend the workflow to tight-junction and viral-entry studies.

• Nanoparticle Uptake by Human Corneal Epithelial Cells

  2026-08-14

  The 2024 ACS Biomaterials Science & Engineering study systematically links PLGA nanoparticle size and surface chemistry with uptake mechanisms in human corneal epithelial cells. Its mucosal in vitro model shows that energy-dependent endocytosis dominates, with macropinocytosis and caveolae-mediated uptake contributing most strongly across the tested formulations.

• LMP2A–mTORC1–GCNT3 Signaling in NPC

  2026-08-13

  A 2024 Virus Genes study identifies an EBV LMP2A–mTORC1–GCNT3 regulatory axis in nasopharyngeal carcinoma (NPC), linking viral signaling to glycosylation, epithelial–mesenchymal transition, migration, and proliferation. The work provides a mechanistic framework for studying how EBV latency reshapes tumor-cell behavior, while also defining important limits for translating the findings into pharmacological or non-NPC models.

• A20, Oxidized DNA, and AKI Inflammation

  2026-08-13

  The reference study identifies oxidized self-DNA as a driver of acute kidney injury through coordinated cGAS–STING signaling and NLRP3 inflammasome activation. It further shows that A20 and an A20-derived peptide suppress NEK7-dependent pyroptosis, providing a mechanistically focused strategy for limiting inflammatory renal injury.

• D-Luciferin Workflows for Luciferase Imaging

  2026-08-12

  D-Luciferin supports sensitive firefly luciferase readouts for promoter activity, intracellular ATP quantification, pharmacodynamic studies, and longitudinal tumor burden assessment. This practical guide connects substrate handling and kinetic imaging with assay choices inspired by a pH-responsive glioblastoma siRNA study.

• Cyanine 3-dCTP for Reliable DNA Labeling

  2026-08-12

  Learn how Cyanine 3-dCTP (SKU B8159) can complement cell viability, proliferation, and cytotoxicity assays through direct enzymatic labeling of DNA and cDNA. This scenario-based guide covers polymerase compatibility, incorporation ratios, probe workflows, data interpretation, and practical supplier-selection criteria.

• Kir4.1–Panx3 Signaling in Orofacial Neuropathic Pain

  2026-08-11

  Feng et al. identify a Kir4.1–ROS–p38 MAPK–Panx3 axis in trigeminal ganglion satellite glial cells during orofacial neuropathic pain. The study combines nerve-injury modeling, targeted gene manipulation, behavioral testing, and pathway pharmacology to connect potassium-channel dysfunction with pain sensitization.

• SB743921: From Mitotic Arrest to Assay Meaning

  2026-08-11

  SB743921 is a selective kinesin spindle protein inhibitor whose mitotic effects require more than a single viability endpoint. This guide connects KSP biology with the relative-versus-fractional viability framework to improve cancer research assay interpretation.

• IWR-1-endo: From Pathway Blockade to Phenotype

  2026-08-10

  IWR-1-endo is a Wnt signaling inhibitor that enables mechanism-aware studies of β-catenin biology. This article connects its pathway activity with high-content morphological profiling, assay design, and translational interpretation in colorectal cancer research and regenerative models.

• ZK53: Human Mitochondrial ClpP Activator

  2026-08-09

  ZK53 is a selective human mitochondrial serine protease ClpP activator for mechanistic cancer research. It activates HsClpP, disrupts mitochondrial electron transport, triggers DNA-damage and cell-cycle responses, and sensitizes tumor cells to ferroptosis inducers.

8648 records 3/577 page Previous Next 12345 下5页 Last page